Rajat Bansal
- Urology top 10%
-
- CAR-T cell therapy research 10
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 3
-
- Cytomegalovirus and herpesvirus research 5
-
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Parvovirus B19 Infection Studies 3
- Co-authors
- Mikhail A. NikiforovYing V. ZhangTudorita TumbarJayhun LeeDavid J. McDermittSanjeev K. WaghmareRan ReshefNausheen Ahmed
- Cited by
- UrologyOncologyHematology
- Journals
- Blood (8 papers)Transplantation and Cellular Therapy (6 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United StatesIndiaRussia
In The Last Decade
Rajat Bansal
34 papers receiving 476 citations
Peers
Comparison fields: 5 of 67
- Urology 58
- Oncology 200
- Hematology 75
- Aging 9
- Cell Biology 58
Countries citing papers authored by Rajat Bansal
This map shows the geographic impact of Rajat Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajat Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajat Bansal more than expected).
Fields of papers citing papers by Rajat Bansal
This network shows the impact of papers produced by Rajat Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajat Bansal. The network helps show where Rajat Bansal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rajat Bansal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 77 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 26 | |
| 16 | 2014 | 21 | |
| 17 | 2014 | 2 | |
| 18 | 2013 | 2 | |
| 19 | 2010 | 30 | |
| 20 | 2008 | 113 |
About Rajat Bansal
Rajat Bansal is a scholar working on Hematology, Transplantation and Periodontics, having authored 38 papers that have together received 485 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), CAR-T cell therapy research (10 papers), Acute Myeloid Leukemia Research (5 papers), Cytomegalovirus and herpesvirus research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Parvovirus B19 Infection Studies (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Urology (58 citations), Oncology (200 citations) and Hematology (75 citations). Rajat Bansal has collaborated with scholars based in United States, India and Russia. Frequent co-authors include Mikhail A. Nikiforov, Ying V. Zhang, Tudorita Tumbar, Jayhun Lee, David J. McDermitt, Sanjeev K. Waghmare, Ran Reshef, Nausheen Ahmed, Muhammad Umair Mushtaq and Leyla Shune. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Frontiers in Oncology, Journal of Clinical Oncology and Transplant Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.